0.13Open0.05Pre Close3 Volume164 Open Interest85.00Strike Price43.00Turnover100.49%IV8.58%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.0809Delta0.0360Gamma522.80Leverage Ratio-0.1500Theta0.0002Rho42.31Eff Leverage0.0062Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet